Effects of Spinal vs General Anesthesia on Systemic Inflammation in PCNL
NCT ID: NCT07326670
Last Updated: 2026-01-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
90 participants
OBSERVATIONAL
2025-10-15
2026-04-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Inflammatory Response Under Spinal vs General Anesthesia in PCNL: NLR, RDW, LAR.
NCT07205224
Effects of Anesthesia Type on Inflammatory Response
NCT06984315
Spinal Versus General Anesthesia and Inflammatory Response Measured by Delta Neutrophil Index in Total Knee Arthroplasty: An Observational Study
NCT07214558
Is Low Flow Anaesthesia Feasible?
NCT06389669
Effect of Anesthesia Method on Neutrophil-Lymphocyte Ratio
NCT05628935
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Spinal Anesthesia Group
Patients undergoing percutaneous nephrolithotomy under spinal anesthesia as part of routine clinical practice. No additional intervention is performed for the purposes of the study.
No interventions assigned to this group
General Anesthesia Group
Patients undergoing percutaneous nephrolithotomy under general anesthesia as part of routine clinical practice. No additional intervention is performed for the purposes of the study.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients aged 18 years and older
Exclusion Criteria
* Patients younger than 18 years
* Active infection or diagnosis of sepsis
* Malignancy
* Chronic inflammatory diseases (e.g., rheumatoid arthritis, systemic lupus erythematosus)
* Use of immunosuppressive therapy
* Pregnancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Elazıg Fethi Sekin Sehir Hastanesi
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sevim Şenol Karataş
Specialist in Anesthesiology and Reanimation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fethi Sekin City Hospital
Elâzığ, Elaziğ, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PCNL-ANES-INFLAM-2025
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.